The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 10, 2023

Filed:

Jun. 15, 2018
Applicant:

Ucl Business Ltd, London, GB;

Inventors:

Stephanie Schorge, London, GB;

Matthew Charles Walker, London, GB;

Dimitri M. Kullmann, London, GB;

Albert Snowball, London, GB;

Elodie Chabrol, London, GB;

Assignee:

UCL BUSINESS LTD, London, GB;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C12N 15/86 (2006.01); C07K 14/705 (2006.01); A61K 38/17 (2006.01); A61P 25/08 (2006.01); C12Q 1/6876 (2018.01);
U.S. Cl.
CPC ...
A61K 48/0058 (2013.01); A61K 38/177 (2013.01); A61P 25/08 (2018.01); C07K 14/705 (2013.01); C12N 15/86 (2013.01); C12Q 1/6876 (2013.01); C12N 2740/15043 (2013.01); C12N 2740/15052 (2013.01); C12N 2830/008 (2013.01); C12Q 2600/158 (2013.01);
Abstract

The invention provides expression vectors, nucleic acids, vector particles and methods of treatment involving these vector particles, comprising an engineered KCNA1 gene encoding an edited Kv1.1 potassium channel, as well as methods of confirming the presence of engineered KCNA1 mRNA in a cell. The features of the engineered KCNA1 gene combine to advantageously enhance the translation and activity of the Kv1.1 protein and improve detection of KCNA1 gene expression in a cell and can be used for example in the treatment of epilepsy and similar neurological disorders.


Find Patent Forward Citations

Loading…